Acceleron Careers

Patients

Hematology

The American Society of Hematology (ASH)
The American Society of Hematology (ASH)

ASH’s mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.

The European Hematology Association (EHA)
The European Hematology Association (EHA)

EHA serves medical professionals, researchers, and scientists with an active interest in hematology. The EHA is proud to be the largest European-based organization connecting hematologists worldwide to support career development and research, harmonize hematology education, and advocate for hematologists and hematology.

Pulmonary

American Heart Association (AHA)
American Heart Association (AHA)

The American Heart Association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke and funds innovative research, fights for stronger public health policies, and provides critical tools and information to save and improve lives.

American Thoracic Society (ATS)
American Thoracic Society (ATS)

The American Thoracic Society is a nonprofit organization focused on improving care for pulmonary diseases, critical illnesses and sleep-related breathing disorders.

Pulmonary Vascular Research Institute (PVRI)
Pulmonary Vascular Research Institute (PVRI)

The Pulmonary Vascular Research Institute is the only global medical research charity fighting PVD. Their mission is to improve the care of patients with PVD throughout the world by raising awareness of PVD, facilitating research and encouraging the development of medicines to treat PVD.

Chest Foundation
Chest Foundation

The mission of the CHEST Foundation is to champion lung health by supporting clinical research grants, community service, and patient education.

American Lung Association
American Lung Association

The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy.

Neuromuscular

American Academy of Neurology (AAN)
American Academy of Neurology (AAN)

The American Academy of Neurology (AAN) is a professional society representing over 34,000 neurologists and neuroscientists and was established in 1948 by A.B. Baker of the University of Minnesota to advance the art and science of neurology, and thereby promote the best possible care for patients with neurological disorders.

Muscular Dystrophy Association (MDA)
Muscular Dystrophy Association (MDA)

MDA is leading the fight to free individuals — and the families who love them — from the harm of muscular dystrophy, ALS and related muscle-debilitating diseases that take away physical strength, independence and life.

Peripheral Nerve Society (PNS)
Peripheral Nerve Society (PNS)

The Peripheral Nerve Society (PNS) is an international organization of physicians and scientists working together to develop and provide the best treatments for people who have peripheral nerve diseases.

- World Muscle Society (WMS)
World Muscle Society (WMS)

WMS was founded in London, UK in 1995, to provide a multidisciplinary scientific forum to advance and disseminate knowledge in the neuromuscular field for the benefit of patients; to stimulate, encourage and help to develop programs for professionals working in the neuromuscular field; to encourage multidisciplinary collaboration; to provide opportunities for young investigators in the neuromuscular field; and to promote the achievement of standards in clinical practice.

Rare Diseases

NORD: National Organization for Rare Disorders
NORD: National Organization for Rare Disorders

NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services.

EveryLife Foundation for Rare Diseases
EveryLife Foundation for Rare Diseases

We are dedicated to advancing the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy.